Literature DB >> 35138625

Ion Channels in Anesthesia.

Wei Zhou1, Zhonghui Guan2.   

Abstract

Ion channels play a pivotal role in anesthesia, including general and regional anesthesia. Two main classes of general anesthetics (GAs) are inhalational anesthetics, such as isoflurane, sevoflurane, and nitrous oxide; injectable anesthetics, such as propofol, etomidate, and ketamine. Besides hypnotic agents, muscle relaxants for immobility and opioids for analgesia are needed to achieve balanced anesthesia. Although our understanding of anesthesia is far from complete, recent studies have revealed the molecular interactions between anesthetic drugs and ion channels, particularly, the ligand-gated ion channels (LGICs). Ionotropic GABAA receptors (GABAARs), the main mediators of the inhibitory signals in the central nervous system (CNS), are the key to hypnosis by general anesthetics. Ionotropic cholinergic receptors (nAChRs), expressed at the neuromuscular junction and the nervous system, are the molecular targets of muscle relaxants. GABAARs and nAChRs belong to the same family of pentameric LGICs. With a completely different architecture, ionotropic glutamate receptors (iGluRs) carry the excitatory signals in the CNS and are targeted by inhalational anesthetics and ketamine. Another distinct family of ion channels, two-pore-domain K+ (K2P) channels, can be activated by inhalational anesthetics and cause neuron hyperpolarization. In this chapter, we will discuss the recent advance in understanding the molecular mechanisms underlying anesthesia through the molecular structures of these ion channels.
© 2021. Springer Nature Singapore Pte Ltd.

Entities:  

Keywords:  Anesthetics; Cholinergic receptors; Etomidate; GABAA receptors; Glutamate receptors; Isoflurane; Ketamine; Nitrous oxide; Propofol; Sevoflurane; Two-pore-domain K+ channels

Mesh:

Substances:

Year:  2021        PMID: 35138625     DOI: 10.1007/978-981-16-4254-8_19

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  83 in total

Review 1.  Structure and pharmacology of pentameric receptor channels: from bacteria to brain.

Authors:  Pierre-Jean Corringer; Frédéric Poitevin; Marie S Prevost; Ludovic Sauguet; Marc Delarue; Jean-Pierre Changeux
Journal:  Structure       Date:  2012-06-06       Impact factor: 5.006

Review 2.  Modulation of voltage-dependent calcium channels by G proteins.

Authors:  G W Zamponi; T P Snutch
Journal:  Curr Opin Neurobiol       Date:  1998-06       Impact factor: 6.627

3.  Principles of activation and permeation in an anion-selective Cys-loop receptor.

Authors:  Ryan E Hibbs; Eric Gouaux
Journal:  Nature       Date:  2011-05-15       Impact factor: 49.962

Review 4.  The Role of GABA Receptor Agonists in Anesthesia and Sedation.

Authors:  Janette Brohan; Basavana G Goudra
Journal:  CNS Drugs       Date:  2017-10       Impact factor: 5.749

Review 5.  Ion channel regulation by G proteins.

Authors:  K Wickman; D E Clapham
Journal:  Physiol Rev       Date:  1995-10       Impact factor: 37.312

Review 6.  Evolutionary history of the ligand-gated ion-channel superfamily of receptors.

Authors:  M O Ortells; G G Lunt
Journal:  Trends Neurosci       Date:  1995-03       Impact factor: 13.837

7.  Nonhalogenated alkane anesthetics fail to potentiate agonist actions on two ligand-gated ion channels.

Authors:  D E Raines; R J Claycomb; M Scheller; S A Forman
Journal:  Anesthesiology       Date:  2001-08       Impact factor: 7.892

Review 8.  Molecular mechanisms of opioid receptor-dependent signaling and behavior.

Authors:  Ream Al-Hasani; Michael R Bruchas
Journal:  Anesthesiology       Date:  2011-12       Impact factor: 7.892

9.  Contrasting synaptic actions of the inhalational general anesthetics isoflurane and xenon.

Authors:  S L de Sousa; R Dickinson; W R Lieb; N P Franks
Journal:  Anesthesiology       Date:  2000-04       Impact factor: 7.892

10.  Alpha5GABAA receptors regulate the intrinsic excitability of mouse hippocampal pyramidal neurons.

Authors:  Robert P Bonin; Loren J Martin; John F MacDonald; Beverley A Orser
Journal:  J Neurophysiol       Date:  2007-08-22       Impact factor: 2.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.